RM-581

A formidable weapon against cancer in the making

RM-581 is a molecule in early development. It has demonstrated its ability to block the progression or even reduce the size of cancerous tumours that are difficult to treat with conventional chemotherapy.

Read more
decoration

OUR MISSION

Giving patients a second chance

Our mission is to develop new treatments for cancers that are particularly difficult to treat with the current therapeutic arsenal, and which are behind a large number of deaths every year in Canada.

Read more
Notre mission
Notre mission
Investors

INVESTORS

Investing in the future

Research investment into new cancer treatments is crucial to increasing life expectancy and improving patient well-being. Scientific advances are offering promising prospects for more effective, less toxic therapies. Financial support helps in speeding up these discoveries and bringing hope to millions of people affected by this disease.

Contact us

NEWS

3 June 2024

Agreement to grant Université Laval an exclusive licence option for the commercial exploitation of aminosteroid derivatives.

21 May 2024

Obtained funding from the MITACS ELEVATION programme to support new work on aminosteroid derivatives.

14 March 2024

Obtained funding from the Programme de soutien aux organismes (PSO) of the Ministère de l’Économie, de l’Innovation et de l’Énergie.

PARTNERS